Drug Type Unknown |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Frostbite | NDA/BLA | US | 30 Nov 2022 | |
Scleroderma, Systemic | Phase 3 | US | 30 Nov 2022 | |
Extracorporeal membrane oxygenation complication | Preclinical | US | 30 Nov 2022 |